IL1B and periodontitis: Furthermore, the use of LDN57444, a specific UCH‐L1 inhibitor, enhanced the osteogenesis of PDLSCs exposed to tumour necrosis factor alpha (TNF‐α) or IL‐1β, suggesting a destructive role of UCH‐L1 in periodontitis progression.